Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination

Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination

Abstract Objective Antitumor viral vaccines, and more particularly poxviral vaccines, represent an active field for clinical development and translational research. To improve the efficacy and treatment outcome, new viral vectors are sought, with emphasis on their abilities to stimulate innate immun...

Full description

Bibliographic Details
Main Authors: Rodrigo Nalio Ramos, Caroline Tosch, Fiorella Kotsias, Marie‐Christine Claudepierre, Doris Schmitt, Christelle Remy‐Ziller, Chantal Hoffmann, Marine Ricordel, Virginie Nourtier, Isabelle Farine, Laurence Laruelle, Julie Hortelano, Clementine Spring‐Giusti, Christine Sedlik, Christophe Le Tourneau, Caroline Hoffmann, Nathalie Silvestre, Philippe Erbs, Kaidre Bendjama, Christine Thioudellet, Eric Quemeneur, Eliane Piaggio, Karola Rittner
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Clinical & Translational Immunology
Subjects:
adaptive immunity
IFN‐α
innate immunity
intratumoral injection
Poxviral cancer vaccine
Online Access:https://doi.org/10.1002/cti2.1392

Internet

https://doi.org/10.1002/cti2.1392

Similar Items